- Home
- PAC vs ASND Comparison
PAC vs ASND Comparison
Compare PAC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAC
- ASND
- Stock Information
- Founded
- PAC 1998
- ASND 2006
- Country
- PAC Mexico
- ASND Denmark
- Employees
- PAC N/A
- ASND N/A
- Industry
- PAC Aerospace
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- PAC Consumer Discretionary
- ASND Health Care
- Exchange
- PAC Nasdaq
- ASND Nasdaq
- Market Cap
- PAC 8.1B
- ASND 7.8B
- IPO Year
- PAC 2006
- ASND 2015
- Fundamental
- Price
- PAC $176.99
- ASND $142.87
- Analyst Decision
- PAC Strong Buy
- ASND Strong Buy
- Analyst Count
- PAC 2
- ASND 12
- Target Price
- PAC $170.00
- ASND $187.08
- AVG Volume (30 Days)
- PAC 69.6K
- ASND 708.3K
- Earning Date
- PAC 10-21-2024
- ASND 11-05-2024
- Dividend Yield
- PAC 3.44%
- ASND N/A
- EPS Growth
- PAC N/A
- ASND N/A
- EPS
- PAC 1.00
- ASND N/A
- Revenue
- PAC $1,340,452,608.00
- ASND $340,327,869.00
- Revenue This Year
- PAC $26.05
- ASND $34.82
- Revenue Next Year
- PAC $9.24
- ASND $72.71
- P/E Ratio
- PAC $17.41
- ASND N/A
- Revenue Growth
- PAC N/A
- ASND 166.54
- 52 Week Low
- PAC $107.25
- ASND $85.29
- 52 Week High
- PAC $197.31
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- PAC 60.21
- ASND 63.73
- Support Level
- PAC $166.76
- ASND $111.09
- Resistance Level
- PAC $179.83
- ASND $126.95
- Average True Range (ATR)
- PAC 5.46
- ASND 4.94
- MACD
- PAC 0.31
- ASND 0.05
- Stochastic Oscillator
- PAC 85.37
- ASND 96.99
About PAC Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.